共 79 条
- [1] Jones PA(2016)Targeting the cancer epigenome for therapy Nat Rev Genet 17 630-641
- [2] Issa JP(2020)Epigenetics in health and disease Adv Exp Med Biol 1253 3-55
- [3] Baylin S(2018)Epigenetics in ovarian cancer: premise, properties, and perspectives Mol Cancer 17 109-30
- [4] Zhang L(2018)Jemal A (2018) Cancer statistics CA Cancer J clin 68 7-105
- [5] Lu Q(2016)The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours Eur Urol 70 93-1401
- [6] Chang C(2011)Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma Oncogene 30 1390-9
- [7] Yang Q(2016)DNA methylation markers for oral pre-cancer progression: a critical review Oral Oncol 53 1-1428
- [8] Siegel RL(2016)The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma Clin Epigenetics 8 43-2018
- [9] Miller KD(2016)DNA methylation in urothelial carcinoma Epigenomics 8 1415-1760
- [10] Moch H(2017)A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients Clin Cancer Res 23 2006-1339